Facciorusso A - Search Results

1

Nucleos(t)ide analogues and Hepatitis B virus-related hepatocellular carcinoma: A literature review.

Abd El Aziz MA, Sacco R, Facciorusso A. Abd El Aziz MA, et al. Among authors: facciorusso a. Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620921331. doi: 10.1177/2040206620921331. Antivir Chem Chemother. 2020. PMID: 32418480 Free PMC article. Review.

2

Pathways and gene expression profiles in hepatocellular carcinoma.

Facciorusso A, Nacchiero MC, Rosania R, Laonigro G, Giorgio F, Del Prete V, Panella C, Ierardi E. Facciorusso A, et al. Minerva Gastroenterol Dietol. 2012 Mar;58(1):35-48. Minerva Gastroenterol Dietol. 2012. PMID: 22419003 Review.

3

Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation.

Facciorusso A, Del Prete V, Antonino M, Neve V, Crucinio N, Di Leo A, Carr BI, Barone M. Facciorusso A, et al. J Gastroenterol Hepatol. 2014 Nov;29(11):1905-10. doi: 10.1111/jgh.12618. J Gastroenterol Hepatol. 2014. PMID: 24731153

4

Letter: prognostic scoring systems for hepatocellular carcinoma patients--the jury is still out.

Facciorusso A, Muscatiello N, Barone M. Facciorusso A, et al. Aliment Pharmacol Ther. 2015 Mar;41(6):596-7. doi: 10.1111/apt.13078. Aliment Pharmacol Ther. 2015. PMID: 25659216 No abstract available.

5

Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma.

Viganò M, Bhoori S, Lampertico P, Donato MF, Iavarone M, Grossi G, Facciorusso A, Caccamo L, Rossi G, Colombo M, Mazzaferro V. Viganò M, et al. Among authors: facciorusso a. Liver Int. 2015 Sep;35(9):2187-93. doi: 10.1111/liv.12835. Epub 2015 Apr 21. Liver Int. 2015. PMID: 25809541

6

MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma.

Facciorusso A, Licinio R, Carr BI, Di Leo A, Barone M. Facciorusso A, et al. Expert Rev Gastroenterol Hepatol. 2015 Jul;9(7):993-1003. doi: 10.1586/17474124.2015.1040763. Epub 2015 Apr 27. Expert Rev Gastroenterol Hepatol. 2015. PMID: 25915713 Review.

7

Medical Systemic Therapies for Hepatocellular Carcinoma: Clinical Perspectives and Safety Profile.

Facciorusso A, Antonino M, Del Prete V, Amoruso A, Neve V, Barone M. Facciorusso A, et al. Curr Drug Saf. 2015;10(3):202-7. doi: 10.2174/1574886310666150521124222. Curr Drug Saf. 2015. PMID: 25994808 Review.

8

Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.

Facciorusso A, Di Maso M, Muscatiello N. Facciorusso A, et al. Int J Hyperthermia. 2016 May;32(3):339-44. doi: 10.3109/02656736.2015.1127434. Epub 2016 Jan 21. Int J Hyperthermia. 2016. PMID: 26794414 Free article. Review.

9

Quality assessment of studies comparing percutaneous ablative treatments in hepatocellular carcinoma.

Facciorusso A, Muscatiello N. Facciorusso A, et al. Int J Hyperthermia. 2016 May;32(3):346-7. doi: 10.3109/02656736.2016.1166526. Epub 2016 Apr 26. Int J Hyperthermia. 2016. PMID: 27117697 Free article. No abstract available.

10

Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma.

Citterio D, Facciorusso A, Sposito C, Rota R, Bhoori S, Mazzaferro V. Citterio D, et al. Among authors: facciorusso a. JAMA Surg. 2016 Sep 1;151(9):846-53. doi: 10.1001/jamasurg.2016.1121. JAMA Surg. 2016. PMID: 27248425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters